n 251 patients over a period of 15 years an uncemented Kotz modular femoral and tibial reconstruction mega prosthesis was implanted after resection of a malignant tumour of the lower limb. Twenty-one patients (8.4%) underwent revision for aseptic loosening, again using an uncemented prosthesis, and five of these required a further revision procedure. The median follow-up time from the first revision was 60 months (11 to 168) and after a second revision, 33 months (2 to 50). The probability of a patient avoiding aseptic loosening for ten years was 96% for a proximal femoral, 76% for a distal femoral and 85% for a proximal tibial implant.
I
n 251 patients over a period of 15 years an uncemented Kotz modular femoral and tibial reconstruction mega prosthesis was implanted after resection of a malignant tumour of the lower limb. Twenty-one patients (8.4%) underwent revision for aseptic loosening, again using an uncemented prosthesis, and five of these required a further revision procedure. The median follow-up time from the first revision was 60 months (11 to 168) and after a second revision, 33 months (2 to 50). The probability of a patient avoiding aseptic loosening for ten years was 96% for a proximal femoral, 76% for a distal femoral and 85% for a proximal tibial implant.
At the time of follow-up all radiographs were assessed according to the International Symposium of Limb Salvage criteria. The first radiological signs of aseptic loosening were always seen at the most proximal or distal part of the anchorage stem at a mean of 12 months (4 to 23) after the first implantation. Using the Musculoskeletal Tumor Society score for evaluation, the clinical results showed a mean of 88% of normal function. [Br] 2002;84-B:401-6.
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Various methods of segmental reconstruction have been described in an attempt to achieve limb salvage in tumour surgery. These include arthrodesis with autografts or allografts, rotationplasty, bone transport techniques such as the Ilizarov method and arthroplasty using allografts. [1] [2] [3] [4] [5] Endoprosthetic replacement in the lower limbs has become an established method, giving stability, early weight-bearing and good function. In the last 30 years, the overall five-year survival rate for tumour endoprostheses has increased from 20% to 85%. Recent studies have suggested that aseptic loosening has replaced infection as the most frequent cause of failure. Therefore, the management of aseptic loosening has become the major concern in endoprosthetic reconstruction in limb-salvage surgery. Although the number of revision operations is increasing, information concerning the outcome after aseptic loosening is limited. 25, 27, 29 We present a retrospective study of the complication rates and the functional and radiological outcome after cementless revision operations for aseptic loosening.
Patients and Methods
We reviewed 251 patients who underwent surgery between September 1982 and September 1997. A cementless Kotz modular femoral and tibial reconstruction (KMFTR) or a Howmedica Modular Reconstruction System (HMRS; Howmedica GmBH, Kiel, Germany) endoprosthesis had been implanted after resection of a malignant tumour of the lower limb in all cases. There were 135 men and 116 women with a mean age of 37.6 years at the time of operation. Twenty-one (15 men, 6 women) (8.4%) underwent a revision procedure for aseptic loosening at a mean of 36 months (11 to 121) after implantation ( Table I ). The indications for revision surgery included pain, instability and progressive changes on plain radiographs. The primary malignant tumour had been resected at a mean age of 23.0 years and the gap filled by an endoprosthesis. The primary pathology was osteosarcoma in 17, malignant fibrous histiocytoma in one, Ewing's sarcoma in one and chondrosarcoma in two. The locations were the proximal femur in two, the distal femur in 15, and the proximal tibia in four. Nineteen patients had received neoadjuvant chemotherapy according to the COSS protocol 22, 26, 30 and one according to the T11 protocol. 22, 30 In one patient (case 11) with a local recurrence of a G2 chondrosarcoma, no chemotherapy had been given. Radiotherapy was given to two. In two patients (cases 8 and 16), biopsy and initial chemotherapy and radiotherapy had been carried out in another country. The final clinical and radiological assessments of these 21 patients were undertaken at a mean follow-up of 101 months (47 to 155) after the initial operation. Laboratory tests, CT of the chest, abdominal sonography and 99m Tc bone scanning were performed as well as determination of the International Symposium of Limb Salvage (ISOLS) criteria 31 from a plain radiograph, and the functional Musculoskeletal Tumor Society (MSTS) score. 32 The surgical technique and the details of the prosthesis have been described previously. 8, 16, 17, 20, [33] [34] [35] All operations were carried out in a standardised manner. At the revision procedure, the diaphyseal component was removed, the medullary canal was prepared again and a component with a longer stem and a larger diameter inserted, with adjustments to compensate for any resection of bone stock. Statistical analysis. The overall time free from aseptic loosening was defined as the period between the date of the first implantation and the first revision operation. At the date of the last follow-up, or death of the patient, the respective overall time free from aseptic loosening was considered as 'censored' survival time. The probability of survival of the endoprosthesis was determined by the method of Kaplan and Meier. 36 Differences between the Kaplan-Meier estimate of the overall survival rate without aseptic loosening of 251 patients.
groups were tested according to Mantel. 37 The 95% confidence intervals for the Kaplan-Meier measurements were computed using Greenwood's formula. 38 The SAS statistical analysis system (Version 8; SAS Institute Inc, Cary, North Carolina) was used for all calculations. All p values were the result of two-sided tests with a level of significance of 5%.
Results
We found that the probability of a patient avoiding aseptic loosening for ten years was 96% for a proximal femoral, 76% for a distal femoral and 85% for a proximal tibial implant (Fig. 1) . Figure 2 shows the Kaplan-Meier estimate of the overall time without aseptic loosening. There was a statistically significant difference in the risk of developing aseptic loosening at different sites with the highest incidence being in the distal femur, followed by the proximal tibia and the proximal femur (p = 0.05). The age of the patient, increasing in those under 30 years, was also a significant factor (p = 0.001). Neither local radiotherapy (p = 0.82) nor gender (p = 0.07) had any effect. After the primary procedure 12 patients had developed early complications including haematoma and wound necrosis or dehiscence. Ten had late complications including nerve palsy in three, periprosthetic fractures in four and joint contracture in one. One patient had required a synovectomy and one a reconstruction of the patellar ligament. Two patients had required a musculocutaneous free latissimus dorsi flap. In one patient (case 8) who had had preoperative radiotherapy, a free flap became necessary after four soft-tissue revision procedures had failed, and in another patient (case 20) because of skin necrosis after a wide resection of the knee.
The median time to the first revision operation for aseptic loosening was 27 months (13 to 121) after the initial operation. The initial procedure had been performed for a malignant tumour in the proximal femur in two patients, in the distal femur in 15, in the proximal tibia in three and in both the distal femur and proximal tibia in one. In 18 patients the femoral component and in one the tibial component of the KMFTR prosthesis had to be changed. In two patients both the femoral and tibial anchorages were changed. In seven patients, the same type of implant was used in both the primary and revision procedures; the other 14 patients received a modified HMRS prosthesis at revision (Table I) . 16, 20, 35 In no case was bone cement used.
In six patients no further bone was resected at the time of revision. In 14 the mean resection length was 3.6 cm (Table  I ) and in one (case 11), in which a recurrence of tumour was suspected, a further wide resection including 14 cm of bone was undertaken. Most resections were necessary because of stress resorption of bone under the flanges of the prosthesis. In an attempt to reduce this, the number of flanges in the HMRS prostheses was reduced to one. This may explain the smaller amount of bone resected during the second revision operations. The diameter of the new stem was 1 mm greater than the original in nine patients, 2 mm in three, 3 mm in five and 4 mm in one. Apart from one haematoma, we encountered no soft-tissue complications after the revision operations.
In four patients, aseptic loosening of the prosthesis occurred at a mean of 21 months (9 to 41) after fracture of the stem of the implant. The incidence of complications was the same after the first operation as after the revisions (Table I) . There was one case of nerve palsy (sciatic) and one fracture. Seven patients had late failure of the bushing. In three patients, a one-block bushing was implanted with additional metal rings and in four an HMRS bushing was used. 16, 20, 35 In five patients, a second revision procedure was carried out at a mean of 56.4 months (40 to 72) after the first. Aseptic loosening of a distal femoral component occurred three times, of the proximal femoral component once and of the proximal tibial component once. At the second revision procedure, one patient received a KMFTR and four an HMRS prosthesis. Of the five patients with repeat loosening, one (case 4), had undergone disarticulation through the contralateral knee three years before implantation of the KMFTR prosthesis for osteosarcoma. Although provided with an orthosis, he placed considerable stress on the endoprosthesis. In one patient (case 7), there was loosening of the non-modular femoral stem of a proximal tibial prosthesis. After preoperative radiotherapy and resection of 29 cm of femoral bone, one patient (case 8) required a vascularised free latissimus dorsi flap after four failed soft-tissue revision procedures. Both femoral and tibial components loosened synchronously in one patient (case 15). In another patient (case 16) the bone quality after radiotherapy was compromised causing a pathological fracture around the femoral stem. In only one patient (case 7) was cemented fixation used after a second revision for aseptic loosening had resulted in much bone loss. There were no other complications. The mean follow-up after the second revision operation was 30 months (2 to 50).
The first radiological signs of bone remodelling were seen at a mean of 12 months (4 to 23) after the first operation and of 23.3 months (2 to 117) before the revision operation (Fig. 3) . The first clinical symptoms appeared at a mean of 4.6 months before the revision operation. A longer interval (mean 53.7 months) was found between the first radiological signs of loosening and the second revision operation. The mean duration between the onset of symptoms and the second revision operation was 12 months. At the first sign of aseptic loosening, we found either bone remodelling, sclerosis, resorption, hypertrophy of the cortex or radiolucent lines, around the most proximal or distal regions of the stem. At follow-up all radiographs were assessed to determine bone remodelling and the following were examined; the prosthesis-bone interface, bone anchorage and defects of the implant and its articulation according to the ISOLS criteria (Table II) . Using the MSTS score, pain, function, emotional acceptance, the use of a walking stick and gait were assessed. The clinical results showed a mean functional performance of 88% of normal.
Discussion
Horowitz et al 11 analysed the increasing incidence of aseptic loosening of cemented tumour prostheses in a long-term follow-up study. It was 19% after five years rising to 33% after ten. At five years they reported avoidance of aseptic loosening of 100% in the proximal femur, 78% in the distal femur and 73% in the proximal tibia. The significant increase in aseptic loosening in the long term could explain the better results with cementless tumour prostheses in several studies with a follow-up of only 24 to 51 months. 8, 20, 28 Unwin et al, 23 reviewing 1001 patients with cemented custom-made prostheses, described the chances of avoiding aseptic loosening for ten years to be 93.8% for the proximal femoral, 67.4% for the distal femoral and 58% for the proximal tibial implant. They also reported a correlation between the incidence of aseptic loosening and the age of the patient, the amount of bone removed and time. Studies on rotating-hinge prostheses reported significantly better results, with rates of aseptic loosening of 0% to 10% at a follow-up of between 42 and 134 months. 9, 13 We have used the HMRS with a rotating hinge exclusively since 1996. In our study of the cementless KMFTR prosthesis, with a flexion and extension hinge, we found the chance of avoiding aseptic loosening for ten years to be 96% for the proximal femoral, 76% for the distal femoral and 85% for the proximal tibial implant. Apart from the surgical site (p = 0.05) only the age of the patient at the initial operation (p = 0.001, rising for younger patients) showed a significant variation.
The mean age of the patients in our study, at the time of operation, was 23.0 years. Neither local radiotherapy (p = 0.82) nor gender (p = 0.07) had any influence on the development of aseptic loosening. We found an equal number of complications after the primary implantation as after the revision procedure for aseptic loosening. Ward The functional outcome of an excellent result in 71.5%, good in 19.0% and fair in 9.5% at the final follow-up in our series is comparable with that of other studies after midterm follow-up. Our functional results did not deteriorate after the revision operations. A further argument in favour of cementless revision surgery is the modest diaphyseal bone loss. All five patients with re-relapse of aseptic loosening were very difficult singular cases with extraordinary requirements. Reduction in stress resorption of the bone brought about by implantation of a HMRS prosthesis, careful preparation of the bone with as little damage to the periosteum as possible and an extended long stem-bone anchorage of the prosthesis result in a durable, stable fixation. In these five patients the first radiological signs were found at a mean of ten months (7 to 13) before the revision operation. This, together with the special history and a shorter duration of clinical symptoms, could predict a more fulminant course of aseptic loosening in comparison with the 15 other patients. Before the second revision, radiological symptoms were observed for a mean of 54 months (39 to 90) which is significantly longer than before the first revision.
The first radiological signs of aseptic loosening were found at a mean of 12 months (4 to 23) after implantation and 23 months (2 to 117) before revision surgery. There were radiolucent lines or bone remodelling (sclerosis, resorption, hypertrophy) in all patients around the tip of the stem. Symptoms such as pain, instability and shortening, appeared at a mean of five months before the revision operation. As the onset of symptoms is gradual, most patients found it difficult to state precisely when they started. The question as to whether to respond quickly, at the first sign, either radiological or clinical, of aseptic loosening in order to save as much bone stock as possible, or to delay further surgery as long as possible because of the high incidence of complications, cannot be answered because of the small numbers in this series. Radiological evidence of loosening at the tip of the stem supports the hypothesis of the biomechanical micromovement at the most proximal and distal parts of the rigid implant, as being the cause for loosening, whereas loosening caused by polyethylene wear debris usually starts near the joint. 30 Our study shows that a loose prosthesis can be replaced with another uncemented prosthesis, with no loss of function or adverse radiological features, and that there is no difference between the incidence of complications after the revision and the primary procedures.
